N23785
yx35f09.r1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:263753 5' similar to gb:X04098_cds1 ACTIN, CYTOPLASMIC 2 (HUMAN), mRNA sequence.
601
mRNA
Homo sapiens
MD756027
JP 2019507579-A/23785: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
HZ528566
JP 2016501039-A/23785: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DM760479
JP 2014079248-A/23785: NEISSERIAL ANTIGENIC PEPTIDES.
11
PRT
Neisseria
DJ527585
JP 2010517930-A/23785: Method of constructing and screening libraries of peptide structures.
14
PRT
synthetic construct
MB813043
JP 2019502674-A/23785: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
39
PRT
synthetic construct
PD711699
JP 2021530475-A/23781: De novo Design of Protein Switches.
60
PRT
synthetic construct
LF683006
JP 2016521556-A/23785: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
LV569607
JP 2017029159-A/23785: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
OG660171
JP 2021500321-A/23785: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
HW188813
JP 2013102767-A/23737: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
HV880326
JP 2010507387-A/23737: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
DL614387
JP 2011092200-A/23785: NEISSERIAL ANTIGENIC PEPTIDES.
11
PRT
Neisseria
DJ153165
JP 2007228956-A/23783: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
PA339433
JP 2021522188-A/23785: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
MC552284
JP 2019525738-A/23784: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
19
PRT
synthetic construct
MC907523
JP 2018536623-A/23785: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
37
PRT
synthetic construct
LX121401
JP 2017506877-A/23783: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
LF830941
JP 2016528161-A/23774: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
DJ953150
JP 2010500568-A/39831: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
85
PRT
Homo sapiens
DD550388
JP 2004508801-A/23785: NEISSERIAL ANTIGENIC PEPTIDES.
11
PRT
Neisseria
DM798243
JP 2014068652-A/23785: NEISSERIAL ANTIGENIC PEPTIDES.
11
PRT
Neisseria
PA528269
JP 2022502046-A/11051: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
PA394508
JP 2021533803-A/23591: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
MD269918
JP 2020517247-A/23785: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
MC165629
JP 2019500349-A/23785: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
DL905529
JP 2014205669-A/23785: Method of constructing and screening libraries of peptide structures.
14
PRT
synthetic construct
OG753304
JP 2021120380-A/23785: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
DL032799
JP 2005512499-A/23785: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
785
DNA
synthetic construct
FU798266
JP 2009528046-A/23783: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus